Medicis Pharmaceutical Corp’s newer anti-wrinkle drug Dysport proved significantly better than Botox at improving crow’s feet in a small clinical study, a finding that could give frown lines to market leader Allergan Inc.
Read more:
Botox rival shows crow’s feet advantage in study
If you enjoyed this post, make sure you subscribe to my RSS feed!